The proposal contains three components.

• Component 1 – Establish a national centre for disease control as a new independent statutory body permanently resourced to fulfil a national coordination, advisory, capacity building, and research function. The centre would be responsible for assessing risks relating to communicable diseases and providing briefings, public education, and policy advice on disease threats.
• Component 2 – Provide $1 billion, including departmental costs, in order to build a publicly owned vaccine manufacturing facility. Additional funding required for ongoing operation of the facility would be split 50:50 with State and Territory governments. Vaccine doses produced in excess of domestic requirements would be sold or donated overseas with a 50:50 split.
• Component 3 – Provide $250 million over two years in order to fund vaccine research.

All components are to commence on 1 July 2023.